Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
307.85
-0.86 (-0.28%)
Oct 8, 2025, 9:33 AM EDT - Market open
Cencora Employees
Cencora had 46,000 employees as of September 30, 2024. The number of employees did not change compared to the previous year.
Employees
46,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$6,883,791
Profits / Employee
$41,245
Market Cap
59.69B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 46,000 | 0 | - |
Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
Sep 30, 2020 | 22,000 | 0 | - |
Sep 30, 2019 | 22,000 | 1,000 | 4.76% |
Sep 30, 2018 | 21,000 | 1,000 | 5.00% |
Sep 30, 2017 | 20,000 | 1,000 | 5.26% |
Sep 30, 2016 | 19,000 | 1,500 | 8.57% |
Sep 30, 2015 | 17,500 | 3,500 | 25.00% |
Sep 30, 2014 | 14,000 | 1,000 | 7.69% |
Sep 30, 2013 | 13,000 | -1,500 | -10.34% |
Sep 30, 2012 | 14,500 | 4,200 | 40.78% |
Sep 30, 2011 | 10,300 | 300 | 3.00% |
Sep 30, 2010 | 10,000 | -300 | -2.91% |
Sep 30, 2009 | 10,300 | -600 | -5.50% |
Sep 30, 2008 | 10,900 | -400 | -3.54% |
Sep 30, 2007 | 11,300 | -3,400 | -23.13% |
Sep 30, 2006 | 14,700 | 1,300 | 9.70% |
Sep 30, 2005 | 13,400 | -700 | -4.96% |
Sep 30, 2004 | 14,100 | -700 | -4.73% |
Sep 30, 2003 | 14,800 | 1,100 | 8.03% |
Sep 30, 2002 | 13,700 | 0 | - |
Sep 30, 2001 | 13,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
COR News
- 1 day ago - Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release - Business Wire
- 27 days ago - Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 4 weeks ago - Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Cencora Appoints Mark Durcan as Chairman of Its Board of Directors - Business Wire
- 2 months ago - Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap - Seeking Alpha
- 2 months ago - Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy - Seeking Alpha
- 2 months ago - Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript - Seeking Alpha